Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Vyant Bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 21 | 2 | 26 | +7 |
| Shares | 1.62M | 212.9K | 1.70M | +294.1K (+20.9%) |
| Value | $1.47M | $193.0K | $949.3K | −$329.7K (−25.8%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Vyant Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 21,460 | $12.0K | 0.00% |
| Citadel Advisors LLC | 21,558 | $12.0K | 0.00% |
| Two Sigma Securities, LLC | 21,537 | $12.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 16,605 | $9.27K | 0.00% |
| Susquehanna International Group, LLP | 12,646 | $7.00K | 0.00% |
| Mariner, LLC | 10,273 | $6.00K | 0.00% |
| Advisor Group Holdings, Inc. | 120 | $0 | 0.00% |
Sold out (0)
Institutions that held Vyant Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.
Not filed for Q3 2022 yet (2)
Institutions that held Vyant Bio, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Frontier Wealth Management LLC | 202,601 | $184.0K |
| Taylor Wealth Management Partners | 10,273 | $9.00K |